Search results for "Dizziness"
Little evidence that gabapentinoids work for low back pain
Gabapentin showed minimal improvement of pain compared with placebo, while pregabalin was not as effective compared to other types of analgesic medication, the study showed.
https://immattersacp.org/weekly/archives/2017/08/22/2.htm
22 Aug 2017
New warnings for opioids; approval for arthritis drug
This column reviews a warning on opioid pain drugs and cough medicines combined with benzodiazepines and approval of a new drug to treat multiple inflammatory diseases.
https://immattersacp.org/archives/2016/11/fda.htm
1 Nov 2016
Take time to discuss women's sexual health
A women's sexual health equates to her overall health, and internists should ask about it and refer for it when needed.
https://immattersacp.org/archives/2019/10/take-time-to-discuss-womens-sexual-health.htm
1 Oct 2019
MKSAP Quiz: severe, persistent, burning pain in an assisted-living patient
An 86-year-old woman is evaluated in her assisted-living facility for pain. Four weeks ago, she developed herpetic lesions on her right posterior thorax in a T7 distribution. She was treated with acyclovir, and the lesions healed; however, she has persistent severe burning pain. The pain is so severe that she is unable to leave her bed to attend meals. Following a physical exam, which medication is the most appropriate pharmacologic therapy for this patient's pain?
https://immattersacp.org/weekly/archives/2016/05/17/3.htm
17 May 2016
Warning on IBS drug for patients without gallbladders
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/05/fda.htm
1 May 2017
New diabetes drug, LABA for COPD, skin antibiotic approved
This update covers approval of a sodium-glucose co-transporter 2 inhibitor for diabetes, a once-daily long-acting beta-adrenergic agonist (LABA) for chronic obstructive pulmonary disease (COPD), and a new intravenous drug for bacterial skin and skin-structure infections.
https://immattersacp.org/archives/2014/10/fda.htm
1 Oct 2014
Recommended: Move hydrocodone combo products to schedule II
This regulatory update covers a proposed reclassification of hydrocodone combination products from schedule III to schedule II, and approval of an extended-release version of hydrocodone bitartrate for pain management.
https://immattersacp.org/archives/2014/01/fda.htm
1 Jan 2014
MKSAP Quiz: evaluating ‘a sense of unsteadiness'
This week's quiz asks readers to evaluate ongoing dizziness in an elderly woman.
https://immattersacp.org/weekly/archives/2011/08/09/3.htm
9 Aug 2011
Ventilators, pacemakers recalled; rehab device approved
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/10/ventilators-pacemakers-recalled-rehab-device-approved.htm
1 Oct 2021
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016